Detalhe da pesquisa
1.
Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice.
J Urol
; 210(5): 771-777, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37566643
2.
Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach.
J Urol
; 205(3): 732-739, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33080150
3.
Glypican-1 as a target for fluorescence molecular imaging of bladder cancer.
Int J Urol
; 28(12): 1290-1297, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498294
4.
Clinicopathological characterisation of renal cell carcinoma in young adults: a contemporary update and review of literature.
Histopathology
; 76(6): 875-887, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31872452
5.
Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk Stratification Algorithm Based on Biopsy and Mass Size for Assigning Surveillance versus Treatment of Renal Tumors.
J Urol
; 195(3): 574-80, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26523883
6.
Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and Recurrence.
J Urol
; 196(2): 405-11, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26920466
7.
Independent surgical validation of the new prostate cancer grade-grouping system.
BJU Int
; 118(5): 763-769, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27009882
8.
Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis.
Nat Commun
; 15(1): 4341, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38773085
9.
Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer.
JAMA Oncol
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635241
10.
Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy.
Cancer
; 119(18): 3287-94, 2013 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23821578
11.
Diagnostic accuracy of the PROMIS study.
Lancet
; 390(10092): 362, 2017 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28745602
12.
Certificate of need programs, intensity modulated radiation therapy use and the cost of prostate cancer care.
J Urol
; 189(1): 75-9, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23164382
13.
Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations.
Nat Rev Urol
; 20(4): 205-216, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36600087
14.
Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype.
Cancers (Basel)
; 15(23)2023 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38067234
15.
Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma.
Eur Urol
; 84(2): 166-175, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37085424
16.
MyProstateScore in men considering repeat biopsy: validation of a simple testing approach.
Prostate Cancer Prostatic Dis
; 26(3): 563-567, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36585434
17.
Role of adenosine deaminase in prostate cancer progression.
Am J Clin Exp Urol
; 11(6): 594-612, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38148936
18.
Genomic Tests Should be Used to Help Guide Treatment of Prostate Cancer: Yes.
J Urol
; 198(2): 265-266, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28629664
19.
Factors associated with the adoption of minimally invasive radical prostatectomy in the United States.
J Urol
; 188(3): 775-80, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22818134
20.
Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen.
Urol Oncol
; 40(1): 4.e1-4.e7, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34753659